Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory early phase II study of NS-580 in patients with endometriosis
jRCT2080223592Phase 2Completed
- Sponsor
- Nippon Shinyaku
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in endometriosis comparing NS-580 with Placebo (2 arms). Started Jul 2017; status: completed.
02
Drugs
friluglanstat
03
Conditions
endometriosis
Beyond the preview
Go deeper on jRCT2080223592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223592.